42 studies found for:    " September 05, 2012":" October 05, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
Conditions: Pregnancy;   HIV
Intervention: Procedure: Integrated FP/PNC service delivery
22 Active, not recruiting Increasing Availability and Acceptability of Circumcision in Zambia
Condition: HIV
Intervention: Behavioral: MC and sexual risk reduction
23 Recruiting Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
Conditions: HIV;   Hypercholesterolemia;   Dyslipidemia
Intervention:
24 Completed Observational Study of Male Circumcision Using PrePex Device
Condition: HIV
Intervention: Device: PrePex device for male circumcision
25 Not yet recruiting Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men
Condition: HIV
Interventions: Behavioral: MEN Count;   Behavioral: Comparison
26 Completed Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision
27 Recruiting SANKOFA Pediatric HIV Disclosure Intervention
Condition: HIV
Interventions: Behavioral: Disclosure intervention;   Behavioral: Enhanced usual care
28 Recruiting Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
Condition: HIV
Interventions: Drug: Tenofovir;   Drug: Zidovudine
29 Active, not recruiting Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals
Condition: HIV
Interventions: Biological: 0-24 week prime/boost regimen;   Biological: 0-8 week prime/boost regimen
30 Completed Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
Conditions: Circumcision Adult;   HIV CDC Category B2
Intervention: Device: PrePex™ device
31 Recruiting Effectiveness of P02 Digital Hearing Aids
Conditions: Hearing Loss, Bilateral;   Sensorineural Hearing Loss
Intervention: Procedure: Hearing Aids Evaluation
32 Active, not recruiting Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)
Condition: AIDS
Interventions: Biological: DNA vaccine;   Biological: DNA vaccine prime with the addition of electroporation;   Biological: rTV boost at week 16;   Biological: rTV boost at week 24;   Biological: rTV boost at week 32
33 Recruiting A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique
Conditions: Vaccines;   HIV;   Safety;   Immunogenicity
Interventions: Biological: HIVIS DNA vaccine;   Device: Zetajet;   Device: Derma Vax Electroporation;   Biological: Modified Vaccinia Ankara (MVA-CDMR)
34 Recruiting Rifampin and Nevirapine Interactions in Young Children
Conditions: Tuberculosis;   HIV
Intervention:
35 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
36 Recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
Intervention:
37 Recruiting Rifampin and Efavirenz Interactions in Older Children
Conditions: HIV;   Tuberculosis
Intervention:
38 Active, not recruiting A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
39 Recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
40 Active, not recruiting Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years
Condition: HIV, Pediatric
Interventions: Drug: Atazanavir;   Drug: Ritonavir

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results
Indicates status has not been verified in more than two years